klaw.png
Kuehn Law Encourages FIXX, SCTL, EVRI, and GRPH Investors to Contact Law Firm
01. März 2024 10:48 ET | KUEHN LAW, PLLC
Kuehn Law urges FIXX, SCTL, EVRI, and GRPH investors to engage regarding potential mergers, investigating for shareholder value, disclosure, and fairness.
Homology (FIXX) Alert: Johnson Fistel, Globally-Recognized Law Firm, encourages Long Term Shareholders to Contact the Firm for More Information
06. Juni 2022 11:56 ET | Johnson Fistel, LLP
SAN DIEGO, June 06, 2022 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) against certain...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vertiv, Homology, Volta, and Embark and Encourages Investors to Contact the Firm
23. Mai 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vertiv, Homology, Volta, and Embark and Encourages Investors to Contact the Firm
19. Mai 2022 09:51 ET | Bragar Eagel & Squire
NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vertiv, Homology, Volta, and Embark and Encourages Investors to Contact the Firm
13. Mai 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FAT, Cano, Vertiv, and Homology and Encourages Investors to Contact the Firm
08. Mai 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FAT, Cano, Vertiv, and Homology and Encourages Investors to Contact the Firm
02. Mai 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vertiv, Homology, Volta, and Embark and Encourages Investors to Contact the Firm
27. April 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FAT, Cano, Vertiv, and Homology and Encourages Investors to Contact the Firm
22. April 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
22. April 2022 15:10 ET | The Rosen Law Firm PA
NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June 10,...